Schedule 13G ownership disclosure

ONCOGENEX PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 68230A106

Event date: 2014-06-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-14-003157
Form type
SC 13G
Filer
GREAT POINT PARTNERS LLC
CIK
CIK 1281446
Filed
Jul 07, 2014
Reporting period
Jun 27, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub